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To the Editor,
Recently, the very first plasmid-mediated colistin resistance
(MCR-1) mechanism of resistance in Enterobacteriaceae
was reported from animals, food and patients from China
[1]. Then, it was reported worldwide, mostly in Escherichia
coli. This finding is important since polymyxins are consid-
ered as last resort antibiotics for treating infections due to
multidrug resistant bacteria.
Several pieces of evidence suggest that the reservoir of the
mcr-1 gene might be related to animals, taking into account
the heavy usage of polymyxins in veterinary medicine,
and the fact that this gene was mostly identified from veteri-
nary isolates worldwide. We have reported several human
cases of infections due tomcr-1-positive E. coli from commu-
nity and hospital settings in Switzerland (Geneva and
Neuchâtel regions) in 2015 and 2016 [2, 3]. When used in
human medicine, polymyxins are mostly prescribed in hospi-
tal settings and the extent of diffusion of the mcr-1 gene in
human pathogens remain mostly unknown.
Therefore, a retrospective study was conducted to evaluate
the spread of polymyxin resistance and MCR-1 positivity
among enterobacterial isolates that had been isolated from
clinically-significant specimens, i.e. blood cultures, at the
University Hospital of Lausanne (1,200 beds), Switzerland,
in 2015. This study was performed in the same French-
speaking region of Switzerland as Geneva and Neuchâtel
where mcr-1 positive E. coli isolates had been identified.
A total of 257 non-duplicated enterobacterial isolates was
screened that included E. coli (n = 164), Klebsiella
pneumoniae (n = 41), Enterobacter cloacae (n = 16),
Klebsiella oxytoca (n = 14), Enterobacter aerogenes (n = 6),
Citrobacter koseri (n = 5), Citrobacter freundii (n = 5),
Hafnia alvei (n = 3) Kluyvera ascorbata (n = 1), and
Salmonella serovar enteritidis (n = 2) isolates. The predomi-
nance of E. coli isolates in that collection is in accordance with
the known enterobacterial distribution in bacteremia. The
strains were screened first by using the recently-developed
Rapid Polymyxin NP test that is more reliable and rapid to
detect colistin resistance than disk diffusion, E-test and auto-
mated systems [4, 5]. Then, all strains were screened for the
mcr-1 gene by using regular and real-time PCR techniques [3,
6]. Four isolates (three H. alvei and a single E. cloacae) were
selected as resistant to colistin (prevalence rate, 1.17 %) ac-
cording to the Rapid Polymyxin test. MIC determination con-
firmed that those four strains were indeed resistant to colistin
(MIC > 2 mg/L) [7], the E. cloacae strain showing an
heteroresistance phenotype as known [8]. In fact, H. alvei
might correspond to an enterobacterial subspecies being nat-
urally resistant to polymyxins (P. Nordmann, personal com-
munication). All the strains tested negative for themcr-1 gene.
This study indicated that the extent of diffusion of the mcr-
1 gene is limited at least in this western part Europe. Very
rarely reported in K. pneumoniae, the mcr-1 gene was accord-
ingly not identified here in that species, which is an important
nosocomial gram-negative pathogen. This finding may be
good news for medical specialities that rely on broad-
spectrum antibiotics such as intensive care, heavy surgery
and transplantation units. However, regular screening of
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plasmid-mediated colistin resistance is mandatory to detect
the early occurrence of those polymyxin-resistant isolates
and prevent their further spread.
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